Exactmer Limited

Manufacture of other chemical products n.e.c. · Oxford

ActiveUnited KingdomIncorporated 2017Private Limited Company

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2025-12-31

IXBRL · 134 source facts · 22 selected values

Validation findings

XBRL valid

Reporting period: 2025-01-01 to 2025-12-31
Extraction status: complete
Numeric facts: 68
Documents processed: 1
XBRL standards validation: valid
Filing-profile validation: invalid
Parser: arelle 2.44.4
Taxonomy: FRS-102-2025-01-01.xsd
Currency: GBP
Source identifier: Prod223_4310_11109941_20251231
Source archive: Accounts_Bulk_Data-2026-09-18.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2024-12-31

IXBRL · 145 source facts · 20 selected values

Validation findings

XBRL valid

Reporting period: 2024-01-01 to 2024-12-31
Extraction status: complete
Numeric facts: 79
Documents processed: 1
XBRL standards validation: valid
Filing-profile validation: invalid
Parser: arelle 2.44.4
Taxonomy: FRS-102-2023-01-01.xsd
Currency: GBP
Source identifier: Prod224_2509_11109941_20241231
Source archive: Accounts_Monthly_Data-September2025.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2023-12-31

IXBRL · 127 source facts · 20 selected values

Not assessed

legacy record

Reporting period: 2023-01-01 to 2023-12-31
Extraction status: Legacy / not assessed
Numeric facts: 63
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: FRS-102-2022-01-01.xsd
Currency: GBP
Source identifier: Prod224_2476_11109941_20231231
Source archive: Accounts_Monthly_Data-September2024.zip

Accounts to 2022-12-31

IXBRL · 121 source facts · 20 selected values

Not assessed

legacy record

Reporting period: 2022-01-01 to 2022-12-31
Extraction status: Legacy / not assessed
Numeric facts: 63
Documents processed: Not recorded
XBRL standards validation: Not assessed
Filing-profile validation: Not assessed
Parser: Legacy parser
Taxonomy: FRS-102-2021-01-01.xsd
Currency: GBP
Source identifier: Prod224_0026_11109941_20221231
Source archive: Accounts_Monthly_Data-September2023.zip

Registered details

11109941

Status: Active
Type: Private Limited Company
Incorporated: 2017-12-13
Jurisdiction: —
Registered office: JOHN ECCLES HOUSE, ROBERT ROBINSON AVENUE, OXFORD, OX4 4GP, ENGLAND

Classification

3 SIC codes

205902110032990

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

14 matched grants

Sustainable Separation Membranes for Green Pharmaceutical ManufacturingActive

EPSRC · Research Grant · 2025-05-31 – 2028-05-31 · with 5 other participants

£1,417,965

whole project

Queen Mary University Of LondonleadAstraZenecaAstraZeneca (United Kingdom)Exactmer LimitedMerckThe Sigma-Aldrich Company Limited

Sustainable bioprocess for oligonucleotide manufacture using Nanostar Sieving (BioNanostar)Lead

Innovate UK · Collaborative R&D · 2024-04-01 – 2026-03-31 · with 2 other participants

£570,225

awarded

Exactmer Limitedlead£570,225

Imperial College London£514,590

The University of Manchester£149,802

Maximising Efficiency of Liquid Phase Oligo Synthesis (MELOS)Lead

Innovate UK · Collaborative R&D · 2023-06-01 – 2025-11-30 · with 3 other participants

£702,910

awarded

Exactmer Limitedlead£702,910

Queen Mary University of London£672,104

Centre For Process Innovation Limited£447,567

Astrazeneca UK Limited£0

Nanostar Sieving for multifunctional ADC Linkers: NanoLinkLead

Innovate UK · Collaborative R&D · 2023-01-01 – 2024-04-30

£347,919

awarded

AltOligo: Alternative chemistry for oligonucleotide synthesis using Nanostar Sieving

Horizon Europe Guarantee · EU-Funded · 2023-01-01 – 2025-06-29

£2,155,375

whole project

AltOligo: Alternative chemistry for oligonucleotide synthesis using Nanostar SievingLead

Horizon Europe Guarantee · EU-Funded · 2023-01-01 – 2025-06-29

£2,155,375

whole project

AltOligo: Alternative chemistry for oligonucleotide synthesis using Nanostar SievingLead

Innovate UK · EU-Funded · 2023-01-01 – 2025-06-30

£2,155,375

awarded

Enzymatic methods for assembly of nucleic acid therapeutic agentsActive

BBSRC · Studentship · 2022-09-30 – 2026-09-29 · with 1 other participant

£0

whole project

University Of ManchesterleadExactmer Limited

Isoporous Organic Solvent Nanofitration Membranes to Enable High Value Manufacturing for Life Sciences (iOSN)Lead

UKRI FLF · Fellowship · 2022-06-30 – 2026-06-29 · with 1 other participant

£1,500,000

whole project

Exactmer LimitedleadNorthwestern University

SynHiSelActive

EPSRC · Research Grant · 2022-02-01 – 2027-07-30 · with 19 other participants

£7,328,274

whole project

University Of BathleadBpBritish Standards Institute (BSI Group)Croda InternationalCytiva EuropeDupont Teijin Films (UK) LimitedEvonik Industries AG (International)Exactmer LimitedExxonMobilGraphene Water TechnologiesLaser Micromachining Limited Nanotherics Ltd Naturbeads LtdPall EuropeRFC PowerSigma-AldrichSurface Measurement SystemsUniversity of CantabriaUniversity of MelbourneUniversity of Zaragoza

Accelerating Nanostar Sieving - ACCELOSTARLead

Innovate UK · Study · 2020-11-01 – 2022-03-31

£325,831

awarded

Sustainable Manufacture Oligonucleotides - SuManOLead

Innovate UK · Collaborative R&D · 2020-10-01 – 2021-06-30

£174,308

awarded

Continuation - Scaling up Nanostar SievingLead

Innovate UK · Feasibility Studies · 2020-06-01 – 2020-11-30

£33,467

awarded

Scaling-Up Nanostar Sieving for Manufacture of Exact PolymersLead

Innovate UK · Feasibility Studies · 2019-06-01 – 2020-08-31

£69,953

awarded